Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
about
The structure and function of NKAIN2-a candidate tumor suppressorEZH2 is highly expressed in pituitary adenomas and associated with proliferationThe Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor ShrinkageIdentification of differentially expressed genes in pituitary adenomas by integrating analysis of microarray data.Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.Epigenetic regulation of inflammatory cytokines and associated genes in human malignanciesLocalization and abundance analysis of human lncRNAs at single-cell and single-molecule resolutionProteomic and functional profiles of a follicle-stimulating hormone positive human nonfunctional pituitary adenoma.Expression profiling of O(6) methylguanine-DNA-methyl transferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases.Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.Animal models of pituitary neoplasiaPituitary Medicine From Discovery to Patient-Focused Outcomes.Illuminating somatostatin analog action at neuroendocrine tumor receptorsInducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45γ in human brain malignant glioma (GBM) 8401 cells.DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.Genetic mutations in sporadic pituitary adenomas--what to screen for?The role of genetic and epigenetic changes in pituitary tumorigenesis.Cushing's syndrome: from physiological principles to diagnosis and clinical care.Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells.Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation.Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenoma.Expression and clinical significance of EGR-1 and PTEN in the pituitary tumors of elderly patients.Role of a p53 polymorphism in the development of nonfunctional pituitary adenomasGermline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas.Expression pattern of neuronal intermediate filament α-internexin in anterior pituitary gland and related tumors.Histopathological classification of non-functioning pituitary neuroendocrine tumors.Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.HMGA2 cooperates with either p27(kip1) deficiency or Cdk4(R24C) mutation in pituitary tumorigenesis.DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.Pituitary Gene Signalling PathwayRecent advances in understanding corticotroph pituitary tumor initiation and progression
P2860
Q26771844-0F323444-D5BE-4217-A13D-43E98A317ABCQ27305296-D08A9BD1-0A8F-4310-8C22-F51BA5134FECQ33770763-10BF288A-7223-4A62-8AE3-69ECED36DACBQ34997275-7404CEE8-23EB-41F3-A4FF-7BF44B19CED3Q35054978-3F1D9D24-67FF-444C-B6D9-AC5DE2EBA4B3Q35178132-E6BF32F1-CDCA-45E9-8B12-8A762132D42BQ35204336-72D6A9E0-2D09-4C11-B324-388535AB17EBQ35586819-A55E973B-7910-4DE9-813D-777D789DB157Q35785924-4755CADB-D5BC-48F2-82F4-1625AB679ACAQ36161900-D7CE4AEE-0F40-4984-9D3F-6CE1A76D0180Q36486988-554AB3EC-0EB1-4EEA-8BF5-30E506909182Q36716025-8F328CED-4221-4D53-A34B-C238F510FABFQ37443562-703B76D1-1A83-415F-9775-3F62682570CDQ37620643-63827D98-8ECA-4EB6-BA9E-D6100A1B32EAQ38237444-D9F2A07A-2A9B-4FA9-9EB9-A63ECA1F2D1BQ38263242-C644981D-6B5E-4BD1-94B8-E056B66CCAD4Q38274982-C68E0F49-769D-4227-B610-9A29DFBF706FQ38284048-C3F543EB-8A86-4FDE-A0B2-923A9D9130C9Q38637383-8725820B-851D-4B84-B6B1-77F7C8A54D9CQ38705928-E4DFA348-A1A8-4D75-800D-413908BEAE7AQ39034678-BBA293D8-6666-4634-9AE3-71CDE0F8253EQ40883921-89670A86-A0C6-4258-8F15-4959D4C202F5Q41144088-32434258-EF3F-478C-BE4A-19ABD24F8193Q41358569-D7D226A2-CBA8-4D26-A9DE-8121A2A1E381Q43086692-9C18E800-90F9-4F93-80AA-F516E424CD11Q45986885-DE41E365-179B-4D37-9BC5-1CF88B4ED2D7Q47252651-C7E77C70-0F70-43D0-80A3-9198B3A92425Q47267466-FD390163-564C-4DAF-9FBB-C9F2F3960223Q47382950-484E155D-5181-4061-9604-BE82A599A83AQ47830977-155458DC-3080-49F4-B465-8C297A83884CQ58616038-ED6A9583-5DA4-47BB-B71C-8E561D13E89EQ58694608-240AFA41-5EA6-4D22-A2AA-3742F7629EFF
P2860
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
@en
Genetic and epigenetic mutatio ...... in sporadic pituitary adenoma.
@nl
type
label
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
@en
Genetic and epigenetic mutatio ...... in sporadic pituitary adenoma.
@nl
prefLabel
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
@en
Genetic and epigenetic mutatio ...... in sporadic pituitary adenoma.
@nl
P2860
P1476
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
@en
P2093
P2860
P356
10.1016/J.MCE.2013.09.006
P577
2013-09-11T00:00:00Z